Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
- Chamber
- Senate
- Introduced
- Mar 31, 2026
- Last action
- Jun 5, 2026 — COMMITTED TO RULES
- Session
- 2025-2026
- Momentum
- 40 · Moderate